drugset / Trial / NCT06520553
A Study in Healthy Men to Test How BI 1569912 is Processed in the Body
NaSingle-groupOpen-labelTreatment
Summary
The main objectives of this trial are: * To investigate basic pharmacokinetics of BI 1569912 and total radioactivity, including mass balance, excretion pathways and metabolism following oral administration of BI 1569912 (C-14) to healthy male subjects (test treatment, T). * To investigate the absolute bioavailability of BI 1569912 as single oral solution dose, using a single, concomitant intravenous micro-tracer administration of BI 1569912 (C-13) (reference treatment, R)
Timeline
- Start
- 2024-08-26
- Primary completion
- 2024-10-03
- Completion
- 2024-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1569912 | Unknown | 100 ug | Oral |
| Subject | BI 1569912 | Unknown | 10 mg | Oral |
Indications
No indication recorded.